scispace - formally typeset
L

Lewis L. Lanier

Researcher at University of California, San Francisco

Publications -  576
Citations -  93495

Lewis L. Lanier is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Interleukin 21 & Natural killer cell. The author has an hindex of 159, co-authored 554 publications receiving 86677 citations. Previous affiliations of Lewis L. Lanier include University of Rome Tor Vergata & Cancer Research Institute.

Papers
More filters
Journal Article

Lectin-dependent and anti-CD3 induced cytotoxicity are preferentially mediated by peripheral blood cytotoxic T lymphocytes expressing Leu-7 antigen.

TL;DR: The finding that NK cell-mediated cytotoxicity was unaffected by these lectins refutes the hypothesis that lectin-dependent cellular cytot toxicity is simply a result of effector and target agglutination and represents a population of in vivo primed CTL possibly against viral antigens.
Journal ArticleDOI

Evidence for three types of human cytotoxic lymphocyte

TL;DR: It is argued that functional criteria do not adequately distinguish types of cytotoxic cell, and a classification based on recognition structure is proposed, which identifies three distinct effector cells.
Journal ArticleDOI

Natural killer cells remember: an evolutionary bridge between innate and adaptive immunity?

TL;DR: New findings showing how NK cells possess nearly all of the features of adaptive immunity including memory are proposed, proposing the placement of NK cells as an “evolutionary bridge” between innate and adaptive immunity.